These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7927933)

  • 21. Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas.
    Longman RJ; Douthwaite J; Sylvester PA; O'Leary D; Warren BF; Corfield AP; Thomas MG
    J Clin Pathol; 2000 Feb; 53(2):100-4. PubMed ID: 10767823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered GalNAc-alpha-2,6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma.
    Wang F; Goto M; Kim YS; Higashi M; Imai K; Sato E; Yonezawa S
    J Histochem Cytochem; 2001 Dec; 49(12):1581-92. PubMed ID: 11724906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
    Krishn SR; Kaur S; Smith LM; Johansson SL; Jain M; Patel A; Gautam SK; Hollingsworth MA; Mandel U; Clausen H; Lo WC; Fan WT; Manne U; Batra SK
    Cancer Lett; 2016 May; 374(2):304-14. PubMed ID: 26898938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signet ring cell differentiation in mucinous colorectal carcinoma.
    Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
    Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas.
    Losi L; Scarselli A; Benatti P; Ponz de Leon M; Roncucci L; Pedroni M; Borghi F; Lamberti I; Rossi G; Marino M; Ponti G; Zangardi G; Menigatti M; Di Gregorio C
    Pathol Res Pract; 2004; 200(5):371-7. PubMed ID: 15239345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation.
    Gratchev A; Siedow A; Bumke-Vogt C; Hummel M; Foss HD; Hanski ML; Kobalz U; Mann B; Lammert H; Mansmann U; Stein H; Riecken EO; Hanski C
    Cancer Lett; 2001 Jul; 168(1):71-80. PubMed ID: 11368880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy.
    Osunkoya AO; Adsay NV; Cohen C; Epstein JI; Smith SL
    Mod Pathol; 2008 Jul; 21(7):789-94. PubMed ID: 18487999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum.
    Biemer-Hüttmann AE; Walsh MD; McGuckin MA; Ajioka Y; Watanabe H; Leggett BA; Jass JR
    J Histochem Cytochem; 1999 Aug; 47(8):1039-48. PubMed ID: 10424888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas.
    Mesquita P; Peixoto AJ; Seruca R; Hanski C; Almeida R; Silva F; Reis C; David L
    Cancer Lett; 2003 Jan; 189(2):129-36. PubMed ID: 12490305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
    Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y
    Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities.
    Hara A; Saegusa M; Mitomi H; Kurihara M; Ishihara K; Hotta K; Okayasu I
    Pathol Res Pract; 2000; 196(3):159-66. PubMed ID: 10729920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
    Chang MS; Byeon SJ; Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Park KJ
    Pathobiology; 2012; 79(1):45-53. PubMed ID: 22236547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
    O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
    Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
    Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
    World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.